Preeclampsia accounts for 12% – 16% of maternal deaths in the United States, and 15% of preterm births. According to the US Preventive Services Task Force, an effective, inexpensive, and simple intervention exists to reduce rates of preeclampsia, and by many reports it appears to be underutilized. Pharmacists and providers can play a key role in reducing barriers to low-dose aspirin intake by women at risk for preeclampsia, and organizations that reach high-risk women have a key role to play in raising awareness.
This webinar will be on January 8, 2018 from 1:00 PM to 2:30 PM CST and will address the evidence and recommendations regarding low-dose aspirin to prevent preeclampsia, and describe a promising initiative intended to increase low-dose aspirin intake by lower income women and women of color. African-American women are at higher risk of entering a pregnancy with chronic hypertension and for developing preeclampsia during pregnancy.
- Charlie Lockwood, MD, MHCM – Dean of the Morsani College of Medicine and Senior Vice President, University of South Florida Health, Professor, Obstetrics and Gynecology
- Jodi Abbott, MD, MS – Assistant Dean of Patient Safety & Quality Improvement Education, Associate Professor Boston University School of Medicine Department of Ob/Gyn Boston Medical Center
- Paul Jarris, MD, MBA (Moderator) – Chief Medical Officer, SVP Mission Impact, March of Dimes Foundation